CERo Therapeutics Holdings, Inc.
Why Robinhood?
You can watch CERO and buy or sell other stocks, ETFs, and their options commission-free!About CERO
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors.
CERO Key Statistics
Stock Snapshot
The current CERo Therapeutics Holdings, Inc.(CERO) stock price is $0.10, with a market capitalization of 19.3M. The stock trades at a price-to-earnings (P/E) ratio of -11.94.
On 2026-03-31, CERo Therapeutics Holdings, Inc.(CERO) stock opened at —, reached a high of —, and a low of —.
The CERo Therapeutics Holdings, Inc.(CERO)'s current trading volume is 0, compared to an average daily volume of 136.31M.
In the last year, CERo Therapeutics Holdings, Inc.(CERO) shares hit a 52-week high of $1,280.00 and a 52-week low of $3.99.
In the last year, CERo Therapeutics Holdings, Inc.(CERO) shares hit a 52-week high of $1,280.00 and a 52-week low of $3.99.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.